Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical services that provides development and consulting services to clinical pharmacology and clinical development spectrum. The company also offers delivery models that include full service, functional service provider, and hybrid service structures. In addition, it delivers phase I  IV clinical trial management, clinical pharmacology, and consulting services. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

Fortrea Holdings Inc.

In a report released today, Jailendra Singh from Truist Financial maintained a Hold rating on Fortrea Holdings Inc., with a price target of $12.00....

Truist Financial Keeps Their Hold Rating on Fortrea Holdings Inc. (FTRE)

Fortrea Holdings Inc. (($FTRE)) has held its Q3 earnings call. Read on for the main highlights of the call. The recent earnings call for Fortrea Ho...

Fortrea Holdings Inc. Navigates Growth and Challenges in Q3 Earnings Call

Fortrea Holdings Inc. (($FTRE)) announced an update on their ongoing clinical study. Fortrea Holdings Inc. is collaborating with Italfarmaco on a P...

Market Cap	$1.03B	P/E Ratio	21.80
52W High	$25.05	52W Low	$3.97
Div Yield	N/A	Payout Ratio	N/A
EPS Growth 3Y	-9075.0%	52W Position	32.9%
Overall Score	50	Value Score	60
Quality Score	--	Technical Score	41

EPS Current Est	$0.5	EPS Next Est	$0.73
EPS Growth Est	+46.0%	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	FTRE	$10.90	+8.57%	942.82K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	FTRE	$10.90	+8.6%	942.82K
3
4
5
6

FTRE

FTRE

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Fortrea Holdings Inc. Data in Excel

Get Fortrea Holdings Inc. Data in Excel